Ecology of anti-biofilm agents I: Antibiotics versus bacteriophages

Pharmaceuticals

Volumn 8, Issue 3, 2015, Pages 525-558

  Abedon, Stephen T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Antibiotics ecology; Biocontrol; Biofilm control; Biofilm eradication; Biofilms; Ecology; Lanchester s laws; Phage therapy

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BIOFILM; BIOTECHNOLOGICAL PROCEDURES; DRUG SYNTHESIS; NONHUMAN; PHAGOCYTOSIS; PHYSICAL TOLERANCE; POPULATION GROWTH; REVIEW;

EID: 84941197638     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph8030525     Document Type: Review

References (129)

1. Bjarnsholt, T. The role of bacterial biofilms in chronic infections. APMIS Suppl. 2013, 121, 1–51.
2. Hokkanen, H.M.T.; Sailer, R.I. Success in classical biological control. Crit. Rev. Plant Sci. 1985, 1, 35–72.
3. Harper, D.R. Biological control by microorganisms. In The Encyclopedia of Life Sciences; John Wiley & Sons: England, UK, 2006; pp.1–10.
4. Jordan, K.; Dalmasso, M.; Zentek, J.; Mader, A.; Bruggeman, G.; Wallace, J.; De, M.D.; Fiore, A.; Prukner-Radovcic, E.; Lukac, M. et al. Microbes versus microbes: Control of pathogens in the food chain. J. Sci. Food Agric. 2014, 94, 3079–3089.
5. Gottlieb, D. The production and role of antibiotics in soil. J. Antibiot. 1976, 29, 987–1000.
6. Audrain, B.; Farag, M.A.; Ryu, C.M.; Ghigo, J.M. Role of bacterial volatile compounds in bacterial biology. FEMS Microbiol. Rev. 2015, 39, 222–233.
7. Schmidt, R.; Cordovez, V.; De Boer, W.; Raaijmakers, J.; Garbeva, P. Volatile affairs in microbial interactions. ISME J. 2015, doi:10.1038/ismej.2015.42.
8. Cotter, P.D.; Ross, R.P.; Hill, C. Bacteriocins—a viable alternative to antibiotics? Nat. Rev. Microbiol. 2013, 11, 95–105.
9. Gill, J.J.; Young, R. Therapeutic applications of phage biology: History, practice and recommendations. In Emerging Trends in Antibacterial Discovery: Answering the Call to Arms; Miller, A.A., Miller, P.F., Eds.; Caister Academic Press: Norfolk, UK, 2011; pp. 367–410.
10. Leiman, P.G.; Shneider, M.M. Contractile tail machines of bacteriophages. Adv. Exp. Med. Biol. 2012, 726, 93–114.
11. Calendar, R.; Abedon, S.T. The Bacteriophages; 2nd ed.; Oxford University Press: Oxford, UK, 2006.
12. Pirnay, J.P.; De, V.D.; Verbeken, G.; Merabishvili, M.; Chanishvili, N.; Vaneechoutte, M.; Zizi, M.; Laire, G.; Lavigne, R.; Huys, I. et al. The phage therapy paradigm: Prêt-à-porter or sur-mesure? Pharm. Res. 2011, 28, 934–937.
13. Chan, B.K.; Abedon, S.T. Phage therapy pharmacology: Phage cocktails. Adv. Appl. Microbiol. 2012, 78, 1–23.
14. Chan, B.K.; Abedon, S.T.; Loc-Carrillo, C. Phage cocktails and the future of phage therapy. Future Microbiol. 2013, 8, 769–783.
15. Schmerer, M.; Molineux, I.J.; Bull, J.J. Synergy as a rationale for phage therapy using phage cocktails. PeerJ 2014, 2, e590.
16. Ceri, H.; Olson, M.E.; Stremick, C.; Read, R.R.; Morck, D.; Buret, A. The calgary biofilm device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 1999, 37, 1771–1776.
17. Macia, M.D.; Rojo-Molinero, E.; Oliver, A. Antimicrobial susceptibility testing in biofilm-growing bacteria. Clin. Microbiol. Infect. 2014, 20, 981–990.
18. Sengupta, S.; Chattopadhyay, M.K.; Grossart, H.P. The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol. 2013, 4, 47.
19. Abedon, S.T. Ecology of anti-biofilm agents II. Bacteriophage exploitation and biocontrol of biofilm bacteria. Pharmaceuticals 2015, 8, 559–589.
20. Jacqueline, C.; Caillon, J. Impact of bacterial biofilm on the treatment of prosthetic joint infections. J. Antimicrob. Chemother. 2014, 69, i37–i40.
21. Pulcini, C.; Mainardi, J.L. Antimicrobial stewardship: An international emergency. Clin. Microbiol. Infect. 2014, 20, 947–948.
22. Smith, R.A.; M'ikanatha, N.M.; Read, A.F. Antibiotic resistance: a primer and call to action. Health Commun. 2015, 30, 309–314.
23. Varughese, C.A.; Vakil, N.H.; Phillips, K.M. Antibiotic-associated diarrhea: A refresher on causes and possible prevention with probiotics—continuing education article. J. Pharm. Pract. 2013, 26, 476–482.
24. Vangay, P.; Ward, T.; Gerber, J.S.; Knights, D. Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 2015, 17, 553–564.
25. Gullberg, E.; Cao, S.; Berg, O.G.; Ilback, C.; Sandegren, L.; Hughes, D.; Andersson, D.I. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011, 7, e1002158.
26. Tello, A.; Austin, B.; Telfer, T.C. Selective pressure of antibiotic pollution on bacteria of importance to public health. Environ. Health Perspect. 2012, 120, 1100–1106.
27. Huang, R.; Ding, P.; Huang, D.; Yang, F. Antibiotic pollution threatens public health in China. Lancet 2015, 385, 773–774.
28. Allen, H.K.; Trachsel, J.; Looft, T.; Casey, T.A. Finding alternatives to antibiotics. Ann. N.Y. Acad. Sci. 2014, 1323, 91–100.
29. Penesyan, A.; Gillings, M.; Paulsen, I.T. Antibiotic discovery: Combatting bacterial resistance in cells and in biofilm communities. Molecules 2015, 20, 5286–5298.
30. Jolivet-Gougeon, A.; Bonnaure-Mallet, M. Biofilms as a mechanism of bacterial resistance. Drug Discov. Today Technol. 2014, 11, 49–56.
31. Olsen, I. Biofilm-specific antibiotic tolerance and resistance. Eur. J. Clin. Microbiol. Infect. Dis. 2015, 34, 877–886.
32. Davies, J. Are antibiotics naturally antibiotics? J. Ind. Microbiol. Biotechnol. 2006, 33, 496–499.
33. Hibbing, M.E.; Fuqua, C.; Parsek, M.R.; Peterson, S.B. Bacterial competition: Surviving and thriving in the microbial jungle. Nat. Rev. Microbiol. 2010, 8, 15–25.
34. Curtright, A.J.; Abedon, S.T. Phage therapy: Emergent property pharmacology. J. Bioanal. Biomed. 2011, S6, doi:10.4172/1948-593X.S6-002.
35. Beloin, C.; Renard, S.; Ghigo, J.M.; Lebeaux, D. Novel approaches to combat bacterial biofilms. Curr. Opin. Pharmacol. 2014, 18, 61–68.
36. Prax, M.; Bertram, R. Metabolic aspects of bacterial persisters. Front Cell Infect. Microbiol. 2014, 4, 148.
37. Conlon, B.P.; Rowe, S.E.; Lewis, K. Persister cells in biofilm associated infections. Adv. Exp. Med. Biol. 2015, 831, 1–9.
38. Dusane, D.H.; Damare, S.R.; Nancharaiah, Y.V.; Ramaiah, N.; Venugopalan, V.P.; Kumar, A.R.; Zinjarde, S.S. Disruption of microbial biofilms by an extracellular protein isolated from epibiotic tropical marine strain of Bacillus licheniformis. PLoS ONE 2013, 8, e64501.
39. Stallings, J.H. Soil produced antibiotics—plant disease and insect control. Bacteriol. Rev. 1954, 18, 131–146.
40. Williams, D.H.; Stone, M.J.; Hauck, P.R.; Rahman, S.K. Why are secondary metabolites (natural products) biosynthesized? J. Nat. Prod. 1989, 52, 1189–1208.
41. Aminov, R.I. The role of antibiotics and antibiotic resistance in nature. Environ. Microbiol. 2009, 11, 2970–2988.
42. Aminov, R.I. Biotic acts of antibiotics. Front Microbiol. 2013, 4, 241.
43. Hall-Stoodley, L.; Costerton, J.W.; Stoodley, P. Bacterial biofilms: From the natural environment to infectious disease. Nat. Rev. Microbiol. 2004, 2, 95–108.
44. Kaplan, J.B. Biofilm dispersal: Mechanisms, clinical implications, and potential therapeutic uses. J. Dent. Res. 2010, 89, 205–218.
45. Williams, G.C. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957, 11, 398–411.
46. Presloid, J.B.; Ebendick-Corp, B.E.; Zarate, S.; Novella, I.S. Antagonistic pleiotropy involving promoter sequences in a virus. J. Mol. Biol. 2008, 382, 342–352.
47. Rodriguez-Verdugo, A.; Carrillo-Cisneros, D.; Gonzalez-Gonzalez, A.; Gaut, B.S.; Bennett, A.F. Different tradeoffs result from alternate genetic adaptations to a common environment. Proc. Natl. Acad. Sci. USA 2014, 111, 12121–12126.
48. Elena, S.F.; Sanjuán, R. Climb every mountain? Science 2003, 302, 2074–2075.
49. Bleich, R.; Watrous, J.D.; Dorrestein, P.C.; Bowers, A.A.; Shank, E.A. Thiopeptide antibiotics stimulate biofilm formation in Bacillus subtilis. Proc. Natl. Acad. Sci. USA 2015, 112, 3086–3091.
50. Narisawa, N.; Haruta, S.; Arai, H.; Ishii, M.; Igarashi, Y. Coexistence of antibiotic-producing and antibiotic-sensitive bacteria in biofilms is mediated by resistant bacteria. Appl. Environ. Microbiol. 2008, 74, 3887–3894.
51. Gilbert, P.; Allison, D.G.; Jacob, A.; Korber, D.; Wolfaart, G.; Foley, I. Immigration of planktonic Enterococcus faecalis cells into mature E. facealis biofilms. In Biofilms: Community Interactions and Control, Wimpenny, J.W.T., Handley, P., Gilbert, P., Lappin-Scott, H.M., Eds.; Bioline: Cardiff, UK, 1997; pp. 133–141.
52. Lanchester, F.W. Aircraft in Warfare, The Dawn of the Fourth Arm; Constable and Company Limited: London, UK, 1916.
53. Tzu, S.; Conners, S.; Giles, L. The Art of War by Sun Tzu, classic ed.; El Paso Norte Press: El Paso, TX, USA, 2009.
54. Borges, R.M. Warring ants: Lessons from Lanchester's laws of combat? J. Biosci. 2002, 27, 75–78.
55. Oliveira, N.M.; Martinez-Garcia, E.; Xavier, J.; Durham, W.M.; Kolter, R.; Kim, W.; Foster, K.R. Biofilm formation as a response to ecological competition. PLoS. Biol. 2015, 13, e1002191.
56. Price-Whelan, A.; Dietrich, L.E.; Newman, D.K. Rethinking “secondary” metabolism: Physiological roles for phenazine antibiotics. Nat. Chem. Biol. 2006, 2, 71–78.
57. Tait, K.; Sutherland, I.W. Antagonistic interactions amongst bacteriocin-producing enteric bacteria in dual species biofilms. J. Appl. Microbiol. 2002, 93, 345–352.
58. Houry, A.; Gohar, M.; Deschamps, J.; Tischenko, E.; Aymerich, S.; Gruss, A.; Briandet, R. Bacterial swimmers that infiltrate and take over the biofilm matrix. Proc. Natl. Acad. Sci. USA 2012, 109, 13088–13093.
59. Brown, M.R. W.; Allison, D.G.; Gilbert, G. Resistance of bacterial biofilms to antibiotics: A growth-rate related effect? J. Antimicrob. Chemother. 1988, 22, 777–780.
60. Rafii, F.; Hart, M.E. Antimicrobial resistance in clinically important biofilms. World J. Pharmacol. 2015, 4, 31–46.
61. Burmolle, M.; Webb, J.S.; Rao, D.; Hansen, L.H.; Sorensen, S.J.; Kjelleberg, S. Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl. Environ. Microbiol. 2006, 72, 3916–3923.
62. Elias, S.; Banin, E. Multi-species biofilms: Living with friendly neighbors. FEMS Microbiol. Rev. 2012, 36, 990–1004.
63. Connell, J.L.; Ritschdorff, E.T.; Whiteley, M.; Shear, J.B. 3D printing of microscopic bacterial communities. Proc. Natl. Acad. Sci. USA 2013, 110, 18380–18385.
64. Burmolle, M.; Ren, D.; Bjarnsholt, T.; Sorensen, S.J. Interactions in multispecies biofilms: Do they actually matter? Trends Microbiol. 2014, 22, 84–91.
65. Jefferson, K.K. What drives bacteria to produce a biofilm? FEMS Microbiol. Lett. 2004, 236, 163–173.
66. Matz, C. Biofilms as refuge against predation. In The Biofilm Mode of Life: Mechanisms and Adaptations, Kjelleberg, S.; Givskov, M., Eds.; Horizon Bioscience: Norfolk, UK, 2007; pp. 195–213.
67. Rao, D.; Webb, J.S.; Kjelleberg, S. Competitive interactions in mixed-species biofilms containing the marine bacterium Pseudoalteromonas tunicata. Appl. Environ. Microbiol. 2005, 71, 1729–1736.
68. Xiao, Y.; Wei, X.; Ebright, R.; Wall, D. Antibiotic production by myxobacteria plays a role in predation. J. Bacteriol. 2011, 193, 4626–4633.
69. McBride, M.J.; Zusman, D.R. Behavioral analysis of single cells of Myxococcus xanthus in response to prey cells of Escherichia coli. FEMS Microbiol. Lett. 1996, 137, 227–231.
70. Kadouri, D.; O'Toole, G.A. Susceptibility of biofilms to Bdellovibrio bacteriovorus attack. Appl. Environ. Microbiol. 2005, 71, 4044–4051.
71. Berleman, J.E.; Allen, S.; Danielewicz, M.A.; Remis, J.P.; Gorur, A.; Cunha, J.; Hadi, M.Z.; Zusman, D.R.; Northen, T.R.; Witkowska, H.E. et al. The lethal cargo of Myxococcus xanthus outer membrane vesicles. Front Microbiol. 2014, 5, 474.
72. Iebba, V.; Totino, V.; Santangelo, F.; Gagliardi, A.; Ciotoli, L.; Virga, A.; Ambrosi, C.; Pompili, M.; De Biase, R.V.; Selan, L. et al.. Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus cystic fibrosis isolates. Front Microbiol. 2014, 5, 280, doi:10.3389/fmicb.2014.00280.
73. Al-Bakri, A.G.; Gilbert, P.; Allison, D.G. Immigration and emigration of Burkholderia cepacia and Pseudomonas aeruginosa between and within mixed biofilm communities. J. Appl. Microbiol. 2004, 96, 455–463.
74. Banks, M.K.; Bryers, J.D. Bacterial species dominance within a binary culture biofilm. Appl. Environ. Microbiol. 1991, 57, 1974–1979.
75. Bull, J.J.; Regoes, R.R. Pharmacodynamics of non-replicating viruses, bacteriocins and lysins. Proc. R. Soc. Lond. B Biol. Sci. 2006, 273, 2703–2712.
76. Abedon, S. Phage therapy pharmacology: Calculating phage dosing. Adv. Appl. Microbiol. 2011, 77, 1–40.
77. Stewart, F.M.; Levin, B.R. The population biology of bacterial viruses: Why be temperate. Theor. Pop. Biol. 1984, 26, 93–117.
78. Paul, J.H. Prophages in marine bacteria: Dangerous molecular time bombs or the key to survival in the seas? ISME J. 2008, 2, 579–589.
79. Gardner, A.; West, S.A.; Buckling, A. Bacteriocins, spite and virulence. Proc. Roy. Soc. Lond. B 2004, 271, 1529–1535.
80. Nedelcu, A.M.; Driscoll, W.W.; Durand, P.M.; Herron, M.D.; Rashidi, A. On the paradigm of altruistic suicide in the unicellular world. Evolution 2011, 65, 3–20.
81. Solheim, H.T.; Sekse, C.; Urdahl, A.M.; Wasteson, Y.; Nesse, L.L. Biofilm as an environment for dissemination of stx genes by transduction. Appl. Environ. Microbiol. 2013, 79, 896–900.
82. Yan, L.; Boyd, K.G.; Adams, D.R.; Burgess, J.G. Biofilm-specific cross-species induction of antimicrobial compounds in bacilli. Appl. Environ. Microbiol. 2003, 69, 3719–3727.
83. Sarkar, S.; Roy, D.; Mukherjee, J. Production of a potentially novel antimicrobial compound by a biofilm-forming marine Streptomyces sp. in a niche-mimic rotating disk bioreactor. Bioprocess. Biosyst. Eng. 2010, 33, 207–217.
84. Kreth, J.; Merritt, J.; Shi, W.; Qi, F. Competition and coexistence between Streptococcus mutans and Streptococcus sanguinis in the dental biofilm. J. Bacteriol. 2005, 187, 7193–7203.
85. Farmer, J.T.; Shimkevitch, A.V.; Reilly, P.S.; Mlynek, K.D.; Jensen, K.S.; Callahan, M.T.; Bushaw-Newton, K.L.; Kaplan, J.B. Environmental bacteria produce abundant and diverse antibiofilm compounds. J. Appl. Microbiol. 2014, 117, 1663–1673.
86. Nadell, C.D.; Drescher, K.; Wingreen, N.S.; Bassler, B.L. Extracellular matrix structure governs invasion resistance in bacterial biofilms. ISME J. 2015, 9, 1700–1709.
87. Kroiss, J.; Kaltenpoth, M.; Schneider, B.; Schwinger, M.G.; Hertweck, C.; Maddula, R.K.; Strohm, E.; Svatos, A. Symbiotic streptomycetes provide antibiotic combination prophylaxis for wasp offspring. Nat. Chem. Biol. 2010, 6, 261–263.
88. Moons, P.; Michiels, C.W.; Aertsen, A. Bacterial interactions in biofilms. Crit. Rev. Microbiol. 2009, 35, 157–168.
89. Prol Garcia, M.J.; D'Alvise, P.W.; Rygaard, A.M.; Gram, L. Biofilm formation is not a prerequisite for production of the antibacterial compound tropodithietic acid in Phaeobacter inhibens DSM 17395. J. Appl. Microbiol. 2014, 117, 1592–1600.
90. Rendueles, O.; Beloin, C.; Latour-Lambert, P.; Ghigo, J.M. A new biofilm-associated colicin with increased efficiency against biofilm bacteria. ISME J. 2014, 8, 1275–1288.
91. Moons, P.; Van, H.R.; Aertsen, A.; Vanoirbeek, K.; Engelborghs, Y.; Michiels, C.W. Role of quorum sensing and antimicrobial component production by Serratia plymuthica in formation of biofilms, including mixed biofilms with Escherichia coli. Appl. Environ. Microbiol. 2006, 72, 7294–7300.
92. Schluter, J.; Nadell, C.D.; Bassler, B.L.; Foster, K.R. Adhesion as a weapon in microbial competition. ISME J. 2015, 9, 139–149.
93. Nadell, C.D.; Bassler, B.L. A fitness trade-off between local competition and dispersal in Vibrio cholerae biofilms. Proc. Natl. Acad. Sci. USA 2011, 108, 14181–14185.
94. Stewart, P.S.; Franklin, M.J. Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 2008, 6, 199–210.
95. Scali, C.; Kunimoto, B. An update on chronic wounds and the role of biofilms. J. Cutan. Med. Surg. 2013, 17, 371–376.
96. Cooper, R.A.; Bjarnsholt, T.; Alhede, M. Biofilms in wounds: A review of present knowledge. J. Wound. Care 2014, 23, 570–580.
97. Levin, S.A. Public goods in relation to competition, cooperation, and spite. Proc. Natl. Acad. Sci. USA 2014, 111, 10838–10845.
98. Mitri, S.; Foster, K.R. The genotypic view of social interactions in microbial communities. Ann. Rev. Genet. 2013, 47, 247–273.
99. Drescher, K.; Nadell, C.D.; Stone, H.A.; Wingreen, N.S.; Bassler, B.L. Solutions to the public goods dilemma in bacterial biofilms. Curr. Biol. 2014, 24, 50–55.
100. Cordero, O.X.; Wildschutte, H.; Kirkup, B.; Proehl, S.; Ngo, L.; Hussain, F.; Le, R.F.; Mincer, T.; Polz, M.F. Ecological populations of bacteria act as socially cohesive units of antibiotic production and resistance. Science 2012, 337, 1228–1231.
101. Hwang, I.Y.; Tan, M.H.; Koh, E.; Ho, C.L.; Poh, C.L.; Chang, M.W. Reprogramming microbes to be pathogen-seeking killers. ACS Synth. Biol. 2014, 3, 228–237.
102. Baelo, A.; Levato, R.; Julian, E.; Crespo, A.; Astola, J.; Gavalda, J.; Engel, E.; Mateos- Timoneda, M.A.; Torrents, E. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. J. Control Release 2015, 209, 150–158.
103. Martin, C.; Low, W.L.; Gupta, A.; Amin, M.C.; Radecka, I.; Britland, S.T.; Raj, P.; Kenward, K.M. Strategies for antimicrobial drug delivery to biofilm. Curr. Pharm. Des. 2015, 21, 43–66.
104. Alhede, M.; Kragh, K.N.; Qvortrup, K.; Allesen-Holm, M.; van Gennip, M.; Christensen, L.D.; Jensen, P.O.; Nielsen, A.K.; Parsek, M.; Wozniak, D. et al. Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. PLoS ONE 2011, 6, e27943.
105. Derlon, N.; Koch, N.; Eugster, B.; Posch, T.; Pernthaler, J.; Pronk, W.; Morgenroth, E. Activity of metazoa governs biofilm structure formation and enhances permeate flux during gravity-driven membrane (GDM) filtration. Water Res. 2013, 47, 2085–2095.
106. Erken, M.; Farrenschon, N.; Speckmann, S.; Arndt, H.; Weitere, M. Quantification of individual flagellate-bacteria interactions within semi-natural biofilms. Protist 2012, 163, 632–642.
107. Abedon, S.T. Bacteriophages and Biofilms: Ecology, Phage Therapy, Plaques; Nova Science Publishers: New York, NY, USA, 2011.
108. Brüssow, H. Bacteriophage-host interaction: From splendid isolation into a messy reality. Curr. Opin. Microbiol. 2013, 16, 500–506.
109. Fan, X.; Li, W.; Zheng, F.; Xie, J. Bacteriophage inspired antibiotics discovery against infection involved biofilm. Crit. Rev. Eukaryot. Gene Expr. 2013, 23, 317–326.
110. Harper, D.R.; Parracho, H.M. R.; Walker, J.; Sharp, R.; Hughes, G.; Werthrén, M.; Lehman, S.; Morales, S. Bacteriophages and biofilms. Antibiotics 2014, 3, 270–284.
111. Parasion, S.; Kwiatek, M.; Gryko, R.; Mizak, L.; Malm, A. Bacteriophages as an alternative strategy for fighting biofilm development. Pol. J. Microbiol. 2014, 63, 137–145.
112. Sillankorva, S.; Azeredo, J. Bacteriophage attack as an anti-biofilm strategy. Methods Mol. Biol. 2014, 1147, 277–285.
113. Sillankorva, S.; Azeredo, J. The use of bacteriophages and bacteriophage-derived enzymes for clinically relevant biofilm control. In Phage Therapy: Current Research and Applications, Borysowski, J., Miedzybrodzki, R.; Górski, A., Eds.; Caister Academic Press: Norfolk, UK, 2014.
114. Chan, B.K.; Abedon, S.T. Bacteriophages and their enzymes in biofilm control. Curr. Pharm. Des. 2015, 21, 85–99.
115. Abedon, S.T. Kinetics of phage-mediated biocontrol of bacteria. Foodborne Pathog. Dis. 2009, 6, 807–815.
116. Kutter, E.; De Vos, D.; Gvasalia, G.; Alavidze, Z.; Gogokhia, L.; Kuhl, S.; Abedon, S.T. Phage therapy in clinical practice: treatment of human infections. Curr. Pharm. Biotechnol. 2010, 11, 69–86.
117. Abedon, S.T.; Kuhl, S.J.; Blasdel, B.G.; Kutter, E.M. Phage treatment of human infections. Bacteriophage 2011, 1, 66–85.
118. Abedon, S.T. Phage therapy of pulmonary infections. Bacteriophage 2015, 10.1080/21597081.2015.1020260.
119. Olszowska-Zaremba, N.; Borysowski, J.; Dabrowska, J.; Górski, A. Phage translocation, safety, and immunomodulation. In Bacteriophages in Health and Disease; Hyman, P., Abedon, S.T., Eds.; CABI Press: Wallingford, UK, 2012; pp. 168–184.
120. Abedon, S.T.; Thomas-Abedon, C. Phage therapy pharmacology. Curr. Pharm. Biotechnol. 2010, 11, 28–47.
121. Abedon, S.T. Phage therapy: Eco-physiological pharmacology. Scientifica 2014, 2014, 581639.
122. Abedon, S.T. Spatial vulnerability: Bacterial arrangements, microcolonies, and biofilms as responses to low rather than high phage densities. Viruses 2012, 4, 663–687.
123. Shen, Y.; Mitchell, M.S.; Donovan, D.M.; Nelson, D.C. Phage-based enzybiotics. In Bacteriophages in Health and Disease; Hyman, P., Abedon, S.T., Eds.; CABI Press: Wallingford, UK, 2012; pp. 217–239.
124. Hyman, P.; Abedon, S.T. Bacteriophage host range and bacterial resistance. Adv. Appl. Microbiol. 2010, 70, 217–248.
125. Abedon, S.T. Envisaging bacteria as phage targets. Bacteriophage 2011, 1, 228–230.
126. Abedon, S.T. Bacterial “immunity” against bacteriophages. Bacteriophage 2012, 2, 50–54.
127. Johnston, N. Viral Trojan horse for combating tuberculosis. Drug Discov. Today 2002, 7, 333–335.
128. Broxmeyer, L.; Sosnowskai, D.; Miltner, E.; Chacón, O.; Wagner, D.; McGarvey, J.; Barletta, R.G.; Bermudez, L.E. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: A model for phage therapy of intracellular bacterial pathogens. J. Infect. Dis. 2002, 186, 1155–1160.
129. Dawkins, R.; Krebs, J.R. Arms races between and within species. Proc. Soc. Exp. Biol. Med. 1979, 205, 489–511.